International Review of Ophthalmology ›› 2023, Vol. 47 ›› Issue (1): 84-91.doi: 10.3760/ cma.j.issn.1673-5803.2023.01.016

Previous Articles     Next Articles

Interleukins and choroidal neovascularization

Zhang Wuyue1,2, Sang Aimin1   

  1. 1 Department of Ophthalmology, Affiliated Hospital of Nantong University, Nantong 226000, China; 2 Nantong University, Nantong 226000, China
  • Received:2022-06-04 Online:2023-02-22 Published:2023-03-11
  • Contact: Sang Aimin, Email: sangam@ntu.edu.cn E-mail:sangam@ntu.edu.cn
  • Supported by:
    Jiangsu Graduate Scientific Research Innovation Program (KYCX21_3115)

Abstract: Choroidal neovascularization (CNV) is a common pathological endpoint of various choroidal retinal diseases and the main cause of irreversible visual impairment in humans. The formation of CNV is a very complex pathophysiological process involving a variety of structural cells, inflammatory cells and inflammatory factors, and is related to local chronic inflammation of the retina. Studies have shown that interleukins (ILs), as a large family of inflammatory cytokines, participate in the occurrence and development of CNV by regulating the expression of pro-angiogenic and anti-angiogenic factors in different immune microenvironments, and regulating the generation and function of ILs may serve as potential therapeutic targets. (Int Rev Ophthalmol, 2023, 47: 84-91)

Key words: interleukins, choroidal neovascularization